Neue Suche | Kongressdetail
mail
Druckansicht
 
 

2nd Next-Generation Conjugates Summit

Evvnt Promotion / evvnt
-
21.02.2023 - 23.02.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 to 17:00
 
Kongressthemen
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1400588-3?pid=4832

Speakers: Christian Marsolais, Senior Vice President and Chief Medical Officer, Theratechnologies Inc., Fu-An Kang, Vice President, Research, MiRecule Inc., and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/1400588-2?pid=4832
Frau Jessica Durston
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developer Pricing - Conference + Workshop Day: USD 4197.00, Drug Developer Pricing - Conference Only: USD 2999.00, Service Provider Pricing - Conference + Workshop Day: USD 4997.00, Service Provider Pricing - Conference Only: USD 3599.00
Teilnehmer erwartet
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteÖsterreichische Akademie der ÄrzteCenter of ExcellenceCharité International AcademyAMREF - African Medical and Research FoundationÄrztekammer für WienAnästhesie in Entwicklungsländern e. V.Hilfswerk Austria